IMPORTANT NOTICE | Mayberry Investments Limited is a cashless institution.

Mayberry Investments Limited is a cashless institution.
Please note that cash deposits into any Mayberry account held at commercial banks, whether made in-branch or via Automated Banking Machines (ABMs), are not accepted and will not be processed. For information on accepted payment methods, please contact your Investment Advisor.

CCC reports 41% decline in six months net profit

July 30, 2025

Caribbean Cement Company Ltd (CCC)

Unaudited financials for the six months ended June 30, 2025:

Caribbean Cement Company Ltd (CCC) for the six months ended June 30, 2025, reported a 7% increase in Revenues totaling $16.33 billion compared to $15.28 billion in the corresponding period last year. Revenues for the second quarter had a 6% increase to close at $8.13 billion compared to $7.67 billion for the comparable quarter of 2024.

Cost of sales amounted to $11.00 billion (2024: $7.79 billion), this represents an increase of 41% year over year. Consequently, gross profit decreased by 29% to $5.33 billion compared to $7.50 billion for the six months ended June 30, 2024. The company booked gross profit of $1.55 billion for the second quarter versus $3.89 billion reported for the similar quarter of 2024.

Operating Expenses increased by 13% to close at $1.65 billion (2024: $1.45 billion). As such, Operating Profit before other income and expenses decreased by 39% from $6.04 billion in 2024 to $3.69 billion in the period under review.

Other expenses for the six months ended June 30, 2025, amounted to $575.08 million, a 15% decrease relative to $679.45 million reported in 2024.

Consequently, Operating profit for the six months ended June 30, 2025, amounted to $3.11 billion, a 42% decrease relative to $5.39 billion reported in 2024. Operating profit for the second quarter amounted to $421.51 million (2024: $2.76 billion). CCC highlighted, “This decline was primarily driven by the planned annual maintenance shutdown, which significantly increased costs during the quarter. While this impacted short-term profitability, the investment is expected to enhance operational efficiency, improve production capacity to meet the demands of the local market, and support the company’s strategic entry into export markets.”

Net Finance Income totalled $115.68 million a 1% increase from the corresponding period last year. (2024: $114.58 million).

Profit before taxation for the six months ended June 30, 2025, amounted to $3.26 billion, a 40% decrease relative to $5.43 billion reported in 2024. Profit before taxation for the second quarter amounted to $500.76 million (2024: $2.80 billion).

Taxation charge for the six months ended June 30, 2025, had a 38% decrease to reach $719.36 million (2024: $1.15 billion). As such, Net Profit for the six months amounted to $2.54 billion, a 41% decrease from the $4.28 billion reported in 2024. For the second quarter, Net Profit was $543.94 million (2024: $2.35 billion).

Consequently, Earnings Per Share for the six months amounted to $2.98 (2024: EPS: $5.03), while Earnings Per Share for the quarter totaled $0.64 (2024: EPS: $2.76). The twelve-month trailing EPS was $4.95, and the number of shares used in these calculations was 851,136,591.

Notably, CCC’s stock price closed the trading period on July 29, 2025, at a price of $84.83 with a corresponding P/E ratio of 17.15x.

Balance Sheet Highlights

The company’s assets totalled $45.21 billion (2024: $39.60 billion). The growth in total assets was primarily driven by a $5.13 billion or 21% increase in “PPE’ from $24.85 billion in 2024 to $29.98 billion in the period.

Shareholder’s equity was $30.85 billion (2024: $28.39 billion), representing a book value per share of $36.24 (2024: $33.36).

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein

More Stories from the Market
shutterstock_148562033
July 16, 2026   Everything Fresh Limited (EFRESH) has advised that a Director purchased 20,000 EFRESH shares on July 2, 2026.   …
shutterstock_148562033
July 16, 2026   Tropical Battery Company Limited (TROPICAL) has advised that a Director sold a total of 3,837,736 TROPICAL shares during th…
shutterstock_148562033
July 16, 2026   Caribbean Flavours and Fragrances Limited (CFF) has advised that a Director purchased a total of 2,000 CFF shares during th…
shutterstock_453968572
July 16, 2026   Scotia Group Jamaica Limited (SGJ) has advised that by Formal Order dated July 15, 2026, the Supreme Court of Jamaica, gran…
shutterstock_316932977-700x441
July 16, 2026 The Statistical Institute of Jamaica (STATIN) reported that as of June 2026, the point-to-point inflation rate was +6.7%, rising from…
shutterstock_537598660
July 16, 2026 Caribbean Cream Limited (KREMI) Unaudited financials for the first quarter ended May 31, 2026: Caribbean Cream Limited (KREMI) for th…
shutterstock_537598660
July 16, 2026 Sygnus Real Estate Finance Limited (SRFJMD) Unaudited financials for the nine months ended May 31, 2026: Sygnus Real Estate Finan…
MIL
July 16, 2026 Mayberry Jamaican Equities Limited (MJE) has advised that the daily Net Asset Value (NAV) for July 10, 2026, was J$9.13. MJE’s closin…